Z-1409-2020 Class II Terminated

Recalled by Baxter Healthcare Corporation — Deerfield, IL

FDA device recall Z-1409-2020 was initiated by Baxter Healthcare Corporation on Nov 15, 2019 and is designated Class II. Reason for recall: There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer. The recall status is terminated (terminated Nov 20, 2020). Affected quantity: 101976 devices.

Recall details

Product Type
Devices
Report Date
Mar 11, 2020
Initiation Date
Nov 15, 2019
Termination Date
Nov 20, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
101976 devices

Product description

Revaclear Capillary Dialyzer 300, REF Revaclear 300 Product Code 114745L

Reason for recall

There is the potential presence of particular matter in the header caps of ten lots the Revaclear 300 Dialyzer.

Distribution pattern

Nationwide

Code information

UDI 07332414123055, Lot Numbers: C419124901, C419125001, C419125101, C419125201, C419125401, C419125501, C419125601, C419125801, C419126001, C419126401

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1409-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1409-2020. Report a data issue: hello@regdatalab.com.